Repositive’s ‘personal shopper’ aims to ease access to its cancer models
Repositive adds a personal shopper service to its platform which holds a directory of cancer models from 14 CROs – with expansion ongoing, says CEO.
Archives for January 31, 2019
First generic to Advair is approved after long wait
GSK’s luck at maintaining sales on its off-patent Advair product has run out, with Mylan’s generic version receiving approval from the US FDA.
Advent invests in global CRDO BioDuro
Advent private equity invests in BioDuro through a partnership as the latter aims to grow its research and drug development offerings.
Charles River expanding assay lineup via Toxys tie-up
Charles River is offering Toxys’ ToxTracker in an agreement that will see its portfolio of genetic toxicology assays expand to customers in North America.
Lupin hit with more regulatory challenges
Lupin’s facility was given six observations after the FDA closed its inspection earlier this month.
Certara updates PBPK simulator to enable more realistic case modeling
Certara launches version 18 of its physiologically-based pharmacokinetic (PBPK) Simcyp Simulator with new features including advanced food staggering and tumor models to optimize trial design and dose selection.
India-based CRO enters US market to support global research
Lambda Therapeutic Research is extending its global footprint to the US with the acquisition of Novum Pharmaceutical Research Services, a CRO based in Pittsburgh, PA.